The global demand for Novel Antiviral Drugs Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022 - 2028. Regarding volume, the market was calculated XX Kilo Tons in 2021 and forecast to touch XX Kilo Tons by 2028 with a CAGR of XX% during 2022-2028.
Novel antiviral drugs are a new class of medications used to treat viral infections, especially the drug resistance influenza. These relatively new molecules do not have a well-defined profile and are continuously modified based on recent observations and studies about the viruses' activity. The efficacy of antiviral drugs is short-lived because of the viruses' ability to mutate and the possibility of the viruses becoming drug-resistant or vaccine-resistant during the course of treatment. Hence the development of novel antiviral drugs is very crucial in controlling the spread of highly contagious viruses. High throughput screening, structure-based drug design enhanced by high throughput chemistry, bioisosteric replacement strategies, and rapid preclinical evaluation will enable many novel antiviral agents' rapid development.
Market Dynamics
The continuous emergence of drug-resistant influenza virus strains, pandemic outbreaks, and seasonal cycles of influenza are the central stimulants for the growth of the novel antiviral drugs market. The increasing prevalence of viral infections and numerous deaths caused by seasonal epidemics like Spanish flu and COVID-19 will further propel this market's growth. Ongoing clinical studies to identify drug combinations to treat emerging and re-emerging viral infections and co-infections will benefit market growth. The use of novel and repositioning techniques in developing new drugs will shorten the time and resources needed to create and market these virus-specific drugs. Adoption of alternative therapies like naturopathy and homeopathy and the availability of vaccines to treat viral infections are a few factors that will restrain the growth of this market.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of novel antiviral drugs. The growth and trends of Novel Antiviral Drugs Industry provide a holistic approach to this study.
Market Segmentation
This section of the novel antiviral drugs market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Reverse Transcriptase Inhibitors
- Protease Inhibitors
- Fusion Inhibitors
- Immune System Modulators
- Other
By Application
- Hepatitis Therapeutics
- HIV/AIDS Therapeutics
- Herpes Therapeutics
- Influenza Therapeutics
- Other
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Novel Antiviral Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Novel Antiviral Drugs Market Share by Region (Representative Graph)
Know more about this report: Download free sample
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the novel antiviral drugs market include Roche Holding AG, GlaxoSmithKline, Bristol-Myers Squibb, AbbVie, Johnson & Johnson, Merck & Co, Novartis, Dr Reddy's, Gilead Sciences, Aurobindo Pharma, Cipla. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.